2006
DOI: 10.1016/j.ymgme.2006.01.013
|View full text |Cite
|
Sign up to set email alerts
|

Association of 3-methylglutaconic aciduria with sensori-neural deafness, encephalopathy, and Leigh-like syndrome (MEGDEL association) in four patients with a disorder of the oxidative phosphorylation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
41
1

Year Published

2008
2008
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 60 publications
(43 citation statements)
references
References 26 publications
1
41
1
Order By: Relevance
“…In 2006, we reported four patients with a distinct clinical phenotype called MEGDEL association (Wortmann et al 2006). These patients presented with neuroradiological evidence of Leigh disease, sensorineural hearing loss, recurrent lactic academia, severe neonatal infections, and hypoglycemia.…”
Section: -Mga-uria Type IV (Mim 250951)mentioning
confidence: 99%
“…In 2006, we reported four patients with a distinct clinical phenotype called MEGDEL association (Wortmann et al 2006). These patients presented with neuroradiological evidence of Leigh disease, sensorineural hearing loss, recurrent lactic academia, severe neonatal infections, and hypoglycemia.…”
Section: -Mga-uria Type IV (Mim 250951)mentioning
confidence: 99%
“…Neurodegeneration in mitochondrial disease is correlated clinically with an increased incidence of upper respiratory tract infections and other common infections (Naviaux, 1999). Other reports have indicated that children and adults with mitochondrial disorders have a high risk of recurrent infection (Edmonds et al, 2002;Edmonds, 2004;Wortmann et al, 2006). Furthermore, recurrent infection has been reported in individuals with specific mitochondrial diseases such as Kearns-Sayre syndrome (Katsanos et al, 2002) and Pearson syndrome (Lacbawan et al, 2000).…”
Section: Dmmbiologistsorg 484mentioning
confidence: 99%
“…Depending on which tissues are affected most severely, the phenotypic outcomes are diverse and can include diabetes, blindness, deafness, stroke-like episodes, epilepsy, ataxia, muscle weakness, exercise intolerance and kidney disease (Wallace et al, 1988;Goto et al, 1992;Tatuch and Robinson, 1993;Mackey et al, 1996;Geromel et al, 2001;Rossignol et al, 2003;McKenzie et al, 2004). A number of reports suggest that mitochondrial disease patients are more susceptible to recurrent bacterial infections, particularly of the respiratory tract (Lacbawan et al, 2000;Edmonds et al, 2002;Katsanos et al, 2002;Ogawa et al, 2003;Edmonds, 2004;Wortmann et al, 2006). However, the mechanisms that underlie such increased susceptibility have not been studied and are not understood.…”
Section: Introductionmentioning
confidence: 99%
“…Besides these well-defined forms of MGTA, an unclassified group known as type IV has been reported in many patients presenting variable psychomotor retardation, spasticity, hypertonicity and cardiomyopathy (Gibson et al, 1991Gunay-Aygun, 2005). Some MGTA patients have elevated lactic acid or citric acid cycle intermediates, as well as abnormalities of the mitochondrial electron transport chain (Ibel et al, 1993;Besley et al, 1995;Ruesch et al, 1996), including deficiency of the activities of respiratory chain complexes I, II, III, IV and V Sweetman and Williams, 2001;Gunay-Aygun, 2005;Wortmann et al, 2006), strongly indicating mitochondrial dysfunction.…”
mentioning
confidence: 99%